Trial Profile
Long-term follow-up observational study of human central nervous system stem cells (HuCNS-SC) as a treatment for chronic spinal cord injury
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 24 Apr 2014
Price :
$35
*
At a glance
- Drugs Adult neural stem cells (Primary)
- Indications Spinal cord injuries
- Focus Adverse reactions
- Sponsors StemCells
- 24 Apr 2014 New trial record